137213-71-9

Upstream product

• 583-39-1 2,3-dihydrobenzimidazol-2-thione 
• 76-83-5 trityl chloride 
• 134469-07-1 Benzimidazol-2-thiol 

Downstream Products

• 26345-73-3 1-(2-hydroxyethyl)-1H-benzo[d]imidazole-2(3H)-thione 
• 21541-32-2 1-(2-thioxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)ethanone 
• 137213-72-0 1-Pentafluorophenylmethyl-1,3-dihydro-benzoimidazole-2-thione 
• 80276-21-7 1-(prop-2-yn-1-yl)-1,3-dihydro-2H-benzimidazole-2-thione 
• 67624-25-3 1-Propylbenzimidazoline-2-thione 
• 87216-53-3 3-allylbenzimidazoline-2-thione 
• 39573-31-4 1-ethyl-1H-benzo[d]imidazole-2(3H)-thione 
• 137213-74-2 1-Pentafluorophenylmethyl-2-tritylsulfanyl-1H-benzoimidazole 
• 137268-22-5 1-Ethyl-2-tritylsulfanyl-1H-benzoimidazole 
• 137213-73-1 1-Allyl-2-tritylsulfanyl-1H-benzoimidazole 
• 137268-21-4 methyl?2?(triphenylmethyl)sulfanylbenzimidazole 

Relevant academic research and scientific papers

Synthesis of N-substituted benzimidazole-2-thiones

General methods were developed for N-substitution of benzimidazoline-2-thione with alkyl, alkenyl, alkynyl and acyl groups using S-tritylation as a protecting reaction.

Tetra- and hexanuclear copper(I) iminothiolate complexes: synthesis, structures, and solid-state thermochromic dual emission in visible and near-infrared regions

Two new photoluminescent multinuclear Cu(I) cluster complexes supported by monoanionic bidentate ligand N-methylbenzimidazolethiolate (Me-bimt–), [Cun(Me-bimt)n] with n = 4 (1) and 6 (2), have been synthesized and structur

Protection of Endogenous Thiols against Methylmercury with Benzimidazole-Based Thione by Unusual Ligand-Exchange Reactions

Organomercurials, such as methylmercury (MeHg+), are among the most toxic materials to humans. Apart from inhibiting proteins, MeHg+ exerts its cytotoxicity through strong binding with endogenous thiols cysteine (CysH) and glutathione (GSH) to form MeHgCys and MeHgSG complexes. Herein, it is reported that the N,N-disubstituted benzimidazole-based thione 1 containing a N?CH2CH2OH substituent converts MeHgCys and MeHgSG complexes to less toxic water-soluble HgS nanoparticles (NPs) and releases the corresponding free thiols CysH and GSH from MeHgCys and MeHgSG, respectively, in solution by unusual ligand-exchange reactions in phosphate buffer at 37 °C. However, the corresponding N-substituted benzimidazole-based thione 7 and N,N-disubstituted imidazole-based thione 3, in spite of containing a N?CH2CH2OH substituent, failed to convert MeHgX (X=Cys, and SG) to HgS NPs under identical reaction conditions, which suggests that not only the N?CH2CH2OH moiety but the benzimidazole ring and N,N-disubstitution in 1, which leads to the generation of a partial positive charge at the C2 atom of the benzimidazole ring in 1:1 MeHg-conjugated complex of 1, are crucial to convert MeHgX to HgS NPs under physiologically relevant conditions.

Novel mercaptobenzimidazole substituted benzotriazole UV absorber and process for preparation thereof

The present invention provides a novel mercaptobenzimidazole substituted benzotriazole UV absorber having the general formula I wherein R1 is selected from the group consisting of hydrogen, halogen, C1 to C12 alkyl, linear